Skip to content
Alpha Edge Investing

Alpha Edge Investing

"Investors operate with limited funds and limited intelligence, they don’t need to know everything. As long as they understand better than others, they have an edge.” – George Soros

  • Home
  • Earnings Updates/ Corporate Actions
  • Research – Equities
  • Research – Fixed Income/ Bonds
  • Research – Unit Trust/ ETF
  • News
  • My Opinions/ Views
  • Others
  • About Me
  • Contact
  • Disclaimer
  • Community and Support Forums
  • Toggle search form

UOBKH: Oversea-Chinese Banking Corp – Buy Target Price $18.28

Posted on November 7, 2022November 7, 2022 By alanyeo No Comments on UOBKH: Oversea-Chinese Banking Corp – Buy Target Price $18.28

3Q22: Gaining Consistency; Scaling Greater Heights

OCBC’s net interest income grew 44% yoy, driven by a massive 54bp yoy NIM expansion in 3Q22. Other non-interest income, including insurance and net trading income, grew 13% yoy. This is the third consecutive quarter of excellence in execution and ROE has risen above 12%. We raise our earnings forecast by 7.8% for 2023 due to the rapid NIM expansion and improvement in cost-to-income ratio. OCBC provides a dividend yield of 4.7%/5.0% for 2022/2023. Maintain BUY. Target price: S$18.28.

RESULTS

• Oversea-Chinese Banking Corp (OCBC) reported net profit of S$1,605m for 3Q22 (up 31% yoy and up 8% qoq), above our forecast of S$1,417m.

• Net interest income crosses the S$2b mark with massive NIM expansion. Loans expanded 6% yoy and 2% qoq, driven by Singapore (+5% yoy), Indonesia (+5% yoy), Greater China (+4% yoy) and rest of the world (+20% yoy) (Australia, the UK and the US). NIM expanded a sizeable 54bp yoy and 35bp qoq to 2.06%, driven by higher asset yield across key markets, which outpaced the rise in funding cost. Net interest income grew 44% yoy to S$2,099m.

• Severe contraction in market-sensitive sources of fee income. Fees declined 20% yoy and 5% qoq. Contribution from wealth management dropped 40% yoy due to a subdued investment climate. AUM was flat yoy and qoq at S$250b. Similarly, contributions from brokerage & fund management declined 22% yoy.

• Other non-interest income grew 13% yoy. Contributions from life and general insurance were resilient at S$318m, up 21% yoy, due to net mark-to-market gains from assets and liabilities of Greater Eastern’s insurance funds. Net trading income was strong at S$194m (+134% yoy) due to growth in customer flow treasury income.

• Cost-to-income improved 6.1ppt yoy to 40.3%. Operating expenses increased 7% yoy in 3Q22. Staff costs increased by 8% yoy due to annual salary increments and higher headcount to support business expansion.

• Asset quality has improved. NPL ratio receded 0.1ppt qoq to 1.2% in 3Q22 due to higher recoveries/upgrades of S$669m for corporate and consumer customers in Malaysia and Indonesia that exited relief programmes.

• Loan-loss coverage was healthy at 108%. Total provisions were S$154m in 3Q22 (1H22: S$116m). General provisions were S$76m with additional general provisions set aside for updates in macroeconomic Variables (MEV) model. Specific provisions included impairment of S$47m for OCBC’s overseas properties.

• OCBC achieved ROE of 12.4% for 3Q22. CET-1 CAR eased 0.5ppt qoq to 14.4%.

Oversea-Chinese_Banking_CorpClick here to Download Full Report in PDF

Share this:

  • Click to share on Twitter (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Telegram (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)
Research - Equities Tags:OCBC

Post navigation

Previous Post: UOBKH: CapitaLand Investment – Buy Target Price $4.13
Next Post: UOBKH: Venture Corporation – Buy Target Price $20.06

Related Posts

DBS: OCBC – Buy Target Price $15.00 Research - Equities
UOBKH: Banking – Singapore (Overweight) Research - Equities
CIMB: OCBC – Add Target Price $13.70 (Previous $15.50) Research - Equities
CIMB: Singapore Banks (Overweight) Research - Equities
Maybank: Singapore Banks Research - Equities
PhillipCapital: Singapore Banking Monthly Research - Equities
Maybank: OCBC Bank – Buy Target Price $14.39 Research - Equities
CIMB: Singapore Banks (Overweight) Research - Equities
Maybank: OCBC Bank – Buy Target Price $14.39 Research - Equities
CIMB: Singapore Banks (Overweight) Research - Equities
PhillipCapital: Singapore Banking Monthly Research - Equities
PhillipCapital: Singapore Banking Monthly – NIM improvement across the board Research - Equities

Leave a Reply

You must be logged in to post a comment.

Login

Log In
Register Lost Password
Get new posts by email
Chat on WhatsApp
  • Earnings Updates/ Corporate Actions
  • My Opinions/ Views
  • News
  • Others
  • Research – Equities
  • Research – Fixed Income/ Bonds
  • Research – Unit Trusts/ ETF

Copyright © 2023 Alpha Edge Investing.

Powered by PressBook Grid Blogs theme